- Country: USA
- Summary: Systematic Testing Of Radionuclides In Preclinical Experiments (Stripe) (R21 Clinical Trial Not Allowed)
- UST Ref No: 110347165
- Deadline: 07 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PA-25-173
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The Stripe Program Seeks To Support Pre-Clinical Research Projects Utilizing State-Of-The-Art Cancer Biology Methods And Model Systems That Study How Radiopharmaceutical Therapy (Rpt) Agents Affect The Biology Of Normal Tissue, Tumor Cells And The Tumor Microenvironment. Ideally, Proposed Aims Will Be Designed To Test Hypotheses On How Rpt Dynamically Impacts Cancer Biology Processes, Which Can Serve As The Pre-Clinical Basis For Developing New Targeting Strategies And Approaches. Studies Supported By This Par Will Ultimately Inform The Rationale And Design Of New Rpt-Based Clinical Trials.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSystematic Testing Of Radionuclides In Preclinical Experiments (Stripe) (R21 Clinical Trial Not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Systematic Testing Of Radionuclides In Preclinical Experiments (Stripe) (R21 Clinical Trial Not Allowed). This tender is published on USARFP under UST Ref No: 110347165 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
